Results 211 to 220 of about 89,423 (306)

BCMA-CD19 armored compound CAR T cells in systemic lupus erythematosus: extended follow-up of a phase 1 clinical trial. [PDF]

open access: yesJ Hematol Oncol
Hong M   +20 more
europepmc   +1 more source

Cognitive behavioural therapy compared to control conditions in treating bulimia nervosa and binge‐eating disorder: A systematic review and meta‐analysis

open access: yesBritish Journal of Clinical Psychology, EarlyView.
Abstract Objective Our systematic review and meta‐analysis aimed to investigate how Cognitive‐Behavioural Therapy (CBT) performs against control conditions, such as waiting‐list, self‐help interventions, psychological and pill placebos and treatment as usual (TAU) in Bulimia Nervosa (BN) and Binge Eating Disorder (BED).
Angeliki L. Sioziou   +10 more
wiley   +1 more source

Leukemia Cutis as a Transient Alarm Bell of Disease Progression in a Patient with Chronic Lymphocytic Leukemia under Watchful Waiting. [PDF]

open access: yesMediterr J Hematol Infect Dis
Landini S   +6 more
europepmc   +1 more source

Deciphering the full spectrum of Castleman diseases based on a cohort of 700 patients in a western country

open access: yesBritish Journal of Haematology, EarlyView.
The spectrum of Castleman diseases has expanded over the past three decades. The phenotype of the diseases varies not only among the three major types but also according to the patient ancestry. Summary Under the Castleman disease (CD) eponym, three distinct diseases sharing common pathological features have been described over time.
Eric Oksenhendler   +4 more
wiley   +1 more source

Altered cytoskeletal integrity underlies impaired platelet shape change and defective thrombus formation in ETV6‐related thrombocytopenia

open access: yesBritish Journal of Haematology, EarlyView.
Summary ETV6‐related thrombocytopenia (ETV6‐RT) is an inherited platelet disorder caused by germline ETV6 variants. Despite recent progress, the mechanisms underlying platelet dysfunction in ETV6‐RT remain unclear. We investigated 12 patients from six families using functional assays, electron microscopy, quantitative proteomics and cytoskeletal ...
Ivan P. Tesakov   +15 more
wiley   +1 more source

Urinary Podocyte Loss is Associated With Treatment Response in Patients With Primary Nephrotic Syndrome. [PDF]

open access: yesKidney Int Rep
van den Berge BT   +8 more
europepmc   +1 more source

Real‐world treatment patterns and outcomes among patients with immune thrombocytopenia (ITP) who switched treatment from eltrombopag or romiplostim to avatrombopag in the United States: Results from the REAL‐AVA 3.5 study

open access: yesBritish Journal of Haematology, EarlyView.
Summary Real‐world data on treatment response after switching between thrombopoietin receptor agonists are limited for patients with immune thrombocytopenia (ITP). The objective of this study is to describe treatment patterns and outcomes in patients with primary ITP who switched from eltrombopag (ELT) or romiplostim (ROMI) to avatrombopag (AVA).
Caroline Piatek   +8 more
wiley   +1 more source

From a novel pathogenic SAMD9L variant to cohort‐wide insights: Whole‐genome sequencing highlights somatic genetic rescue and phenotypic heterogeneity

open access: yesBritish Journal of Haematology, EarlyView.
Summary Germline gain‐of‐function variants in sterile alpha motif domain–containing 9‐like (SAMD9L), located on chromosome 7q, cause a multisystem disorder characterized by bone marrow failure, immunodeficiency and variable neurological involvement. Disease evolution is frequently shaped by somatic genetic rescue (SGR), most commonly through monosomy 7,
Hadjer Dellal   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy